{
  "type": "edition",
  "site": {
    "name": "The Book Quiver",
    "language": "en-US",
    "url": "https://www.bookquiver.com"
  },
  "formats": "Every page has two versions with the same data: JSON (the page address + .json) and markdown (the page address + .md). Append .json or .md to any `url` in this document.",
  "title": "Medullary Thyroid Carcinoma",
  "subtitle": null,
  "url": "https://www.bookquiver.com/friedhelm-raue/medullary-thyroid-carcinoma/9783031803956",
  "publisher": "Springer Nature Switzerland",
  "publisher_series": [],
  "translators": [],
  "medium": "paper",
  "duration_seconds": null,
  "narrators": [],
  "illustrators": [],
  "cover_artists": [],
  "isbn": "978-30-3180-395-6",
  "pages": 307,
  "published": "2025-03-20",
  "language": "en_US",
  "cover": "https://quivercdn.com/covers/springer-nature-switzerland/friedhelm-raue/medullary-thyroid-carcinoma_978-30-3180-395-6-700576eb.webp?v=2026-11-14%2005%3A16%3A30",
  "json": "https://www.bookquiver.com/friedhelm-raue/medullary-thyroid-carcinoma/9783031803956.json",
  "markdown": "https://www.bookquiver.com/friedhelm-raue/medullary-thyroid-carcinoma/9783031803956.md",
  "binding": "Hardcover",
  "description": "Provisional textThis book offers a comprehensive overview of medullary thyroid carcinoma. The coverage includes, but is not limited to, molecular biology and genetics, pathology, clinical presentation, imaging techniques, surgical treatment, and follow-up. Medullary thyroid carcinoma (MTC) is a rare unique tumor which differs from other thyroid tumors by originating from the neuroendocrine C-cell, secreting the specific tumor marker calcitonin. MTC is associated in about 25% of cases with multiple endocrine neoplasia type 2, an autosomal dominant familial disorder causing tumors within various endocrine glands. The molecular genetics of tumor development is clarified: hereditary as well as sporadic MTC are linked to mutations in the RET proto- oncogene coding for a tyrosine kinase. These RET mutations serve as a genetic marker for hereditary MTC and allow for prophylactic thyroidectomy in gene carriers. The RET-tyrosine kinase is also a new therapeutic target using selective tyrosine kinase inhibitors improving the outcome of advanced metastasized MTC. This book will be an ideal source of up-to-date information for a wide range of practitioners, including endocrinologists, oncologists, internal medicine specialists, geneticists, and nuclear medicine physicians.",
  "book": {
    "title": "Medullary Thyroid Carcinoma",
    "slug": "medullary-thyroid-carcinoma",
    "url": "https://www.bookquiver.com/friedhelm-raue/medullary-thyroid-carcinoma"
  },
  "authors": [
    {
      "name": "Friedhelm Raue",
      "slug": "friedhelm-raue",
      "url": "https://www.bookquiver.com/friedhelm-raue"
    },
    {
      "name": "Karin Frank-Raue",
      "slug": "karin-frank-raue",
      "url": "https://www.bookquiver.com/karin-frank-raue"
    }
  ]
}
